News|Articles|January 22, 2026
The Journey from Bench to Patient: Reach First-in-Human to Proof of Concept Trials with Speed, Safety, and Certainty
Author(s)Quotient Sciences
Partnering with an experienced first-in-human specialist such as Quotient Sciences is the key to navigating early development with confidence. Through our work with small molecules and biologics, we provide the expertise, infrastructure, and agility needed to move your novel therapy forward, faster.
Trending on Applied Clinical Trials Online
1
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
2
ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion
3
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
4
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
5